Table 1.

Dose–response characteristics of vaginally applied agents in BLT mice.

Anti-HIV drug	EC50 (µM)	m-value, R2
TDF	4.6a	3.10, 0.977
FTC	0.56a	2.82, 0.966
VRC01-N	0.81b	4.00, 0.970
TDF-FTC-VRC01-N	N/Ac	5.62, 0.980

^aSee Gallay et al.²⁷.

^b0.13 mg mL⁻¹.

^cSee Fig. 3.